Literature DB >> 33341598

Long COVID-19: Challenges in the diagnosis and proposed diagnostic criteria.

A V Raveendran1.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 33341598      PMCID: PMC7737559          DOI: 10.1016/j.dsx.2020.12.025

Source DB:  PubMed          Journal:  Diabetes Metab Syndr        ISSN: 1871-4021


× No keyword cloud information.
Reports from various parts of the world show that significant proportion of people who recovered from COVID-19 suffers from various health issues which are collectively called “long COVID-19” or post COVID-19 syndrome. The common symptoms include fatigue, breathlessness, cough, joint pain, chest pain, muscle aches, headaches and so on. Even though collectively called long COVID-19, researchers identified that it is a collection of at least 4 distinct clinical entities which are post-intensive care syndrome, post-viral fatigue syndrome, permanent organ damage, and long-term COVID-19 syndrome [1]. In our experience in addition to these we identified that drug related side effects, complications of COVID-19 (like pneumothorax, pneumomediastinum, vascular thrombosis leading to pulmonary thromboembolism, myocardial infarction, stroke etc), post-COVID-19 psychological issues and other infections (bacterial, other viral, fungal or re-infection with SARS-CoV-2 itself) can also cause similar symptoms in COVID-19 recovered patients. Careful evaluation to rule out causes unrelated to COVID-19 is important to offer correct treatment. In people infected with SARS-CoV-2, 80% of infections are mild or asymptomatic, 15% are severe infection and 5% are critical infections [2]. Usually in people with mild disease symptoms resolve within 2 weeks, where as in severe illness it may persist for 3–6 weeks [3]. Presence of long COVID-19 challenges the assumption that “mild” disease recover within 2 weeks [4]. There are lots of challenges in the diagnosis of long COVID-19. Those who had history of typical symptoms of acute COVID-19 with positive throat swab RT-PCR, presenting with long duration symptoms, the diagnosis of long COVID is straight forward. But those with acute COVID-19 symptoms and negative throat swab RT-PCR, presenting with long symptoms pose real challenge in day to day clinical practice. Significant proportions of SARS-CoV-2 infected individuals are asymptomatic. And development of long COVID-19 symptoms in those asymptomatic individuals adds to the diagnostic confusion. Similarly the duration of acute symptoms vary in patients again adding confusion to differentiate acute COVID-19 from long COVID-19. Based on our experience and after reviewing relevant literature, we are proposing criteria for the diagnosis of long COVID-19 (Table 1 ).
Table 1

Proposed Diagnostic criteria for Long COVID-19.

Proposed Diagnostic criteria for Long COVID-19
A. ESSENTIAL CRITERIA (Evidence of preceding infection with SARS-CoV-2 within last 2–4 weeks)
Symptomatic
Confirmed
Clinical features consistent with COVID-19, with positive throat swab RT-PCR
Clinical features consistent with COVID-19, with negative throat swab RT- PCR, with positive antibody testing
Probable
Clinical features consistent with COVID-19, with negative throat swab RT-PCR and antibody testing, with CT thorax or chest X ray consistent with COVID-19 in presence of contact with confirmed or suspected case of COVID-19 within 2 weeks of onset of symptoms
Clinical features consistent with COVID-19, with negative throat swab RT-PCR, antibody testing and negative CT thorax and chest X ray in presence of contact with confirmed or suspected case of COVID-19 within 2 weeks of onset of symptoms
Possible
Clinical features consistent with COVID-19, with negative throat swab RT-PCR and antibody testing, with CT thorax or chest X ray consistent with COVID-19 in the absence of contact with confirmed or suspected case of COVID-19 within 2 weeks of onset of symptoms, in the setting of community transmission
Clinical features consistent with COVID-19, with negative throat swab RT-PCR, antibody testing and negative CT thorax and chest X ray in the absence of contact with confirmed or suspected case of COVID-19 within 2 weeks of onset of symptoms, in the setting of community transmission
Doubtful
Clinical features consistent with COVID-19, with negative throat swab RT-PCR, antibody testing and negative CT thorax and chest X ray in the absence of contact with confirmed or suspected case of COVID-19 within 2 weeks of onset of symptoms in the absence of community transmission
Asymptomatic
Confirmed
Either positive throat swab RT-PCR or positive antibody testing or both
Probable
Negative throat swab RT-PCR and antibody testing with CT thorax, chest X ray consistent with COVID-19 in presence of contact with confirmed or suspected case of COVID-19
Possible
Negative throat swab RT-PCR, antibody testing and negative CT thorax and chest X ray in presence of contact with confirmed or suspected case of COVID-19
Doubtful
Negative throat swab RT-PCR, antibody testing and negative CT thorax and chest X ray in the absence of contact with confirmed or suspected case of COVID-19 in the setting of community transmission
B.CLINICAL CRITERIASymptoms of Long COVID-19
Presence of symptoms (new or persistent) like fatigue, breathlessness, cough, joint pain, chest pain, muscle aches, headache and so on which could not be attributed to any other cause
C.DURATION CRITERIADuration
In SARS-CoV-2 infected symptomatic individuals, presence of symptoms
More than 2 weeks in mild diseaseMore than 4 weeks in moderate/severe illnessMore than 6 weeks in critical illness
In SARS-CoV-2 infected asymptomatic individuals, presence of symptoms
Appearance of symptoms after 2 weeks of RT-PCR positivityAppearance of symptoms after 1 weeks of antibody positivityAppearance of symptoms after 2 weeks of positive CT thorax or chest X rayAppearance of symptoms after 2 weeks after contact with suspected or positive case of COVID-19Anytime in doubtful cases

(Note: Those who did not undergo throat swab RT-PCR or antibody testing also considered as test negative).

Proposed Diagnostic criteria for Long COVID-19. (Note: Those who did not undergo throat swab RT-PCR or antibody testing also considered as test negative). Clinical criteria (symptoms of Long COVID-19) after defined time period in presence of essential criteria (evidence of preceding SARS-CoV-2 infection) helps to categorise long COVID-19 as confirmed, probable, possible or doubtful long COVID-19 syndrome (Table 2 ).
Table 2

Proposed Diagnostic criteria for Long COVID-19.

Clinical categoryClinical featuresThroat swab RT-PCRSARS-CoV-2 antibodyChest X ray/CT thoraxHistory of contact with confirmed/suspected case of COVID-19Community spreadClinical status of previous SARS-CoV-2 infectionLong COVID-19 symptom duration
Symptomatic++±±±±ConfirmedMore than 2 weeks in mild diseaseMore than 4 weeks in moderate/severe illnessMore than 6 weeks in critical illness
+-+±±±
+--++±Probable
+---+±
+--+-+Possible
+----+
+-----Doubtful
Asymptomatic-+±±±±ConfirmedAppearance of symptoms after 2 weeks of positive RT-PCR or 1 week of positive antibody testing
--+±±±
---++±ProbableAppearance of symptoms after 2 weeks of positive result or contact
----+±PossibleAppearance of symptoms after 2 weeks of contact with positive case
-----+DoubtfulAnytime
Proposed Diagnostic criteria for Long COVID-19.
  1 in total

1.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.

Authors:  Chaolin Huang; Yeming Wang; Xingwang Li; Lili Ren; Jianping Zhao; Yi Hu; Li Zhang; Guohui Fan; Jiuyang Xu; Xiaoying Gu; Zhenshun Cheng; Ting Yu; Jiaan Xia; Yuan Wei; Wenjuan Wu; Xuelei Xie; Wen Yin; Hui Li; Min Liu; Yan Xiao; Hong Gao; Li Guo; Jungang Xie; Guangfa Wang; Rongmeng Jiang; Zhancheng Gao; Qi Jin; Jianwei Wang; Bin Cao
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

  1 in total
  16 in total

Review 1.  Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)-A Systemic Review and Comparison of Clinical Presentation and Symptomatology.

Authors:  Timothy L Wong; Danielle J Weitzer
Journal:  Medicina (Kaunas)       Date:  2021-04-26       Impact factor: 2.430

2.  Recognizing the Clinical Sequelae of COVID-19 in Adults: COVID-19 Long-Haulers.

Authors:  Sherry Leviner
Journal:  J Nurse Pract       Date:  2021-05-07       Impact factor: 0.767

3.  Long COVID syndrome-associated brain fog.

Authors:  Ali A Asadi-Pooya; Ali Akbari; Amir Emami; Mehrzad Lotfi; Mahtab Rostamihosseinkhani; Hamid Nemati; Zohreh Barzegar; Maryam Kabiri; Zahra Zeraatpisheh; Mohsen Farjoud-Kouhanjani; Anahita Jafari; Sarvin Sasannia; Shayan Ashrafi; Masoume Nazeri; Sara Nasiri; Mina Shahisavandi
Journal:  J Med Virol       Date:  2021-10-24       Impact factor: 20.693

4.  Risk Factors Associated with Long COVID Syndrome: A Retrospective Study.

Authors:  Ali Akbar Asadi-Pooya; Ali Akbari; Amir Emami; Mehrzad Lotfi; Mahtab Rostamihosseinkhani; Hamid Nemati; Zohreh Barzegar; Maryam Kabiri; Zahra Zeraatpisheh; Mohsen Farjoud-Kouhanjani; Anahita Jafari; Fateme Sasannia; Shayan Ashrafi; Masoume Nazeri; Sara Nasiri; Mina Shahisavandi
Journal:  Iran J Med Sci       Date:  2021-11

5.  An mHealth App for Fibromyalgia-like Post-COVID-19 Syndrome: Protocol for the Analysis of User Experience and Clinical Data.

Authors:  Marc Blanchard; Lars Backhaus; Pedro Ming Azevedo; Thomas Hügle
Journal:  JMIR Res Protoc       Date:  2022-02-04

6.  Osteopathy and physiotherapy compared to physiotherapy alone on fatigue in long COVID: Study protocol for a pragmatic randomized controlled superiority trial.

Authors:  Ana Christina Certain Curi; Ana Paula Antunes Ferreira; Leandro Alberto Calazans Nogueira; Ney Armando Mello Meziat Filho; Arthur Sá Ferreira
Journal:  Int J Osteopath Med       Date:  2022-04-04       Impact factor: 2.000

Review 7.  Post-COVID-19 Syndrome and the Potential Benefits of Exercise.

Authors:  Amaya Jimeno-Almazán; Jesús G Pallarés; Ángel Buendía-Romero; Alejandro Martínez-Cava; Francisco Franco-López; Bernardino J Sánchez-Alcaraz Martínez; Enrique Bernal-Morel; Javier Courel-Ibáñez
Journal:  Int J Environ Res Public Health       Date:  2021-05-17       Impact factor: 3.390

8.  Refining "Long-COVID" by a Prospective Multimodal Evaluation of Patients with Long-Term Symptoms Attributed to SARS-CoV-2 Infection.

Authors:  Marc Scherlinger; Renaud Felten; Floriane Gallais; Charlotte Nazon; Emmanuel Chatelus; Luc Pijnenburg; Amaury Mengin; Adrien Gras; Pierre Vidailhet; Rachel Arnould-Michel; Sabrina Bibi-Triki; Raphaël Carapito; Sophie Trouillet-Assant; Magali Perret; Alexandre Belot; Seiamak Bahram; Laurent Arnaud; Jacques-Eric Gottenberg; Samira Fafi-Kremer; Jean Sibilia
Journal:  Infect Dis Ther       Date:  2021-07-10

9.  Defining Post-COVID Symptoms (Post-Acute COVID, Long COVID, Persistent Post-COVID): An Integrative Classification.

Authors:  César Fernández-de-Las-Peñas; Domingo Palacios-Ceña; Víctor Gómez-Mayordomo; María L Cuadrado; Lidiane L Florencio
Journal:  Int J Environ Res Public Health       Date:  2021-03-05       Impact factor: 3.390

Review 10.  Long COVID, a comprehensive systematic scoping review.

Authors:  Hossein Akbarialiabad; Mohammad Hossein Taghrir; Ashkan Abdollahi; Nasrollah Ghahramani; Manasi Kumar; Shahram Paydar; Babak Razani; John Mwangi; Ali A Asadi-Pooya; Leila Malekmakan; Bahar Bastani
Journal:  Infection       Date:  2021-07-28       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.